- Home
- ELMD vs GNLX Comparison
ELMD vs GNLX Comparison
Compare ELMD & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- GNLX
- Stock Information
- Founded
- ELMD 1992
- GNLX 2001
- Country
- ELMD United States
- GNLX United States
- Employees
- ELMD N/A
- GNLX N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- GNLX Health Care
- Exchange
- ELMD Nasdaq
- GNLX Nasdaq
- Market Cap
- ELMD 172.2M
- GNLX 112.8M
- IPO Year
- ELMD 2010
- GNLX 2023
- Fundamental
- Price
- ELMD $20.02
- GNLX $3.41
- Analyst Decision
- ELMD Strong Buy
- GNLX Strong Buy
- Analyst Count
- ELMD 1
- GNLX 4
- Target Price
- ELMD $38.00
- GNLX $17.75
- AVG Volume (30 Days)
- ELMD 116.6K
- GNLX 142.7K
- Earning Date
- ELMD 08-26-2025
- GNLX 08-13-2025
- Dividend Yield
- ELMD N/A
- GNLX N/A
- EPS Growth
- ELMD 60.99
- GNLX N/A
- EPS
- ELMD 0.79
- GNLX N/A
- Revenue
- ELMD $61,439,000.00
- GNLX N/A
- Revenue This Year
- ELMD $17.91
- GNLX N/A
- Revenue Next Year
- ELMD $11.70
- GNLX N/A
- P/E Ratio
- ELMD $25.37
- GNLX N/A
- Revenue Growth
- ELMD 14.85
- GNLX N/A
- 52 Week Low
- ELMD $13.74
- GNLX $1.60
- 52 Week High
- ELMD $35.56
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- ELMD 41.34
- GNLX 64.69
- Support Level
- ELMD $19.84
- GNLX $2.80
- Resistance Level
- ELMD $22.16
- GNLX $3.61
- Average True Range (ATR)
- ELMD 0.82
- GNLX 0.22
- MACD
- ELMD -0.11
- GNLX 0.04
- Stochastic Oscillator
- ELMD 7.17
- GNLX 76.74
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.